The results show the possibility of accurate prediction of malignancy of hepatic tumors with a positive prognostic value of 93.5% using advanced contrast-enhanced ultrasound. Contrast enhancement with SonoVue in combination with quantitative evaluation of contrast-medium dynamics is a valuable tool to discriminate hepatic tumors.
Dirk‐André ClevertF. JungK StockSabine WeckbachStefan FeuerbachM ReiserF. Jung
L. ZieglerRobert T. O’BrienKenneth R. WallerJames A. Zagzebski
Flemming ForsbergJi‐Bin LiuH.-J. ChiouNandkumar M. RawoolLaurence ParkerB.B. Goldberg
Kenji KutaraKazushi AsanoAyako KitoKenji TESHIMAYuka KatoYukie SasakiKazuya EDAMURAHisashi ShibuyaTsuneo SatoAtsuhiko HasegawaShigeo Tanaka